Literature DB >> 30641814

Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.

Senthil Kumar Subramani1, Sunil Mahajan1, Pratibha Chauhan1, Dhananjay Yadav2, Meerambika Mishra3, Umamaheswari Pakkirisamy4, G B K S Prasad5.   

Abstract

BACKGROUND: The aim of this study is to determine the prevalence of Metabolic syndrome (MetS) in the people of Gwalior. Three criteria viz., National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria, International Diabetes Federation (IDF) criteria and Harmonized criteria for MetS were employed to assess the prevalence of metabolic syndrome in this region, their concordance with respect to this population was recorded.
METHODS: The cross-sectional study involved the people, who had attended the Diabetes clinic at the Centre for Translational Research, Jiwaji University during 2015-2017. A total of 1190 participants within the age group of 20-79 years of either gender were included in the study. Anthropometric parameters, blood pressure, blood glucose and lipid profile of all subjects were assessed. Student's 't' test, Kappa statistics and Binary logistic regression model were used to analyze the data.
RESULTS: The percentage of prevalent MetS was found to be 72.7, 50.2 and 53.9 following Harmonized criteria, NCEP ATPIII and IDF criteria respectively. The prevalence was found to be maximum in centrally obese female population, aged between 51 and 60 years with the presence of hyperglycemia and reduced HDL- C. Harmonized and IDF criteria showed good agreement (κ 0.85). Regression analysis showed that, high body mass index, hypertension and dyslipedimia were the most critical predictive risk factors of MetS.
CONCLUSIONS: Maximum prevalence of MetS was recorded when the Harmonized criteria was followed. A good agreement was observed between Harmonized vs. IDF criteria. MetS if detected early especially in apparently healthy subjects; paves way for preventive measures to be designed in order to avert the incidence of diabetes and other risks related to cardio vascular disease.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Central India; Harmonized criteria; Metabolic syndrome; Type II diabetes

Mesh:

Year:  2018        PMID: 30641814     DOI: 10.1016/j.dsx.2018.12.003

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  5 in total

1.  Endocrine Challenges and Metabolic Profile in Recipients of Allogeneic Haematopoietic Stem Cell Transplant: A Cross-Sectional Study from Southern India.

Authors:  Kripa Elizabeth Cherian; Nitin Kapoor; Anup J Devasia; Vikram Mathews; Alok Srivastava; Nihal Thomas; Biju George; Thomas V Paul
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-16       Impact factor: 0.900

2.  Prevalence of Type 2 Diabetes and Prediabetes in the Gwalior-Chambal Region of Central India.

Authors:  Senthil Kumar Subramani; Dhananjay Yadav; Meerambika Mishra; Umamaheswari Pakkirisamy; Prakesh Mathiyalagen; Gbks Prasad
Journal:  Int J Environ Res Public Health       Date:  2019-11-26       Impact factor: 3.390

3.  Prevalence of metabolic syndrome among adult population in India: A systematic review and meta-analysis.

Authors:  Yuvaraj Krishnamoorthy; Sathish Rajaa; Sharan Murali; Tanveer Rehman; Jayaprakash Sahoo; Sitanshu Sekhar Kar
Journal:  PLoS One       Date:  2020-10-19       Impact factor: 3.240

4.  Determinants of metabolic syndrome among patients attending diabetes clinics in two sub-urban hospitals: Bono Region, Ghana.

Authors:  Timothy Agandah Abagre; Delia Akosua Bandoh; Adolphina Addoley Addo-Lartey
Journal:  BMC Cardiovasc Disord       Date:  2022-08-10       Impact factor: 2.174

5.  Relationship of Inflammatory Markers and Metabolic Syndrome in Postmenopausal Women.

Authors:  Renata Vargas Sinatora; Eduardo Federighi Baisi Chagas; Fernando Otavio Pires Mattera; Luciano Junqueira Mellem; Ana Rita de Oliveira Dos Santos; Larissa Pires Pereira; Ana Luíza de Carvalho Aranão; Elen Landgraf Guiguer; Adriano Cressoni Araújo; Jesselina F Dos Santos Haber; Leila Campos Guissoni; Sandra Maria Barbalho
Journal:  Metabolites       Date:  2022-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.